Connect your AI

ADMA Biologics ADMA Business Acquisitions Pro Forma Revenue

Business Acquisitions Pro Forma Revenue at other companies

HWK

HawkinsHWKN

$271.46K+7.8%

Construction PartnersROAD

$773.96M+9.0%

The Baldwin Insurance Group, Inc.BWIN

$532.24M+9.0%

Antero ResourcesAR

$1.29M-44.0%

The Baldwin Insurance Group, Inc.BWIN

$106.1M—

Construction PartnersROAD

$11.01M+1.3%

Segments

By segment

ADMA Bio Manufacturing$113.74M0.0%

Plasma Collection Centers$716K-31.8%

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.02B-54.5%

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:BusinessAcquisitionsProFormaRevenue.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's business acquisitions pro forma revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's business acquisitions pro forma revenue?: ADMA Biologics (ADMA) reported business acquisitions pro forma revenue of $114.49M in Q1 2026.